Dynamic expression of miR-126* and its effects on proliferation and contraction of hepatic stellate cells

FEBS Letters

Volumn 587, Issue 23, 2013, Pages 3792-3801

  Guo, Can Jie ^a   Pan, Qin ^b   Xiong, Hua ^a   Qiao, Yu Qi ^a   Bian, Zhao Lian ^a   Zhong, Wei ^a   Sheng, Li ^a   Li, Hai ^a   Shen, Lei ^a   Hua, Jing ^a   Ma, Xiong ^a   Fang, Jing Yuan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Chronic liver disease; Hepatic stellate cell; miR 126*; Portal hypertension; VEGFA

Indexed keywords

BIOLOGICAL MARKER; LENTIVIRUS VECTOR; MICRORNA 126; VASCULOTROPIN; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL CONTRACTION; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STELLATE CELL;

3′UNTRANSLATED REGION; 3′UTR; AKT; CHRONIC LIVER DISEASE; COL IV; ECM; EGFL7; EPIDERMAL GROWTH FACTOR-1IKE DOMAIN 7; EXTRACELLULAR MATRIX; GENE ONTOLOGY; GO; HA; HE; HEMATOXYLIN/EOSIN; HEPATIC STELLATE CELL; HSC; HYALARONIC ACID; KEGG; KYOTO ENCYCLOPEDIA OF GENES AND GENOMES; LAMININ; LN; MICRORNA; MIR-126(*); MIRNA; PCIII; PHOSPHATIDYLINOSITOL-3-KINASE; PI3K; PORTAL HYPERTENSION; PROCOLLAGEN TYPEIII; PROTEIN KINASE B; TYPE IV COLLAGEN; VAN GIESON; VASCULAR ENDOTHELIAL GROWTH FACTOR; VEGF; VEGFA; VG;

ANIMALS; CELL PROLIFERATION; EXTRACELLULAR MATRIX; HEPATIC STELLATE CELLS; MALE; MICRORNAS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84888005109     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2013.09.047     Document Type: Article

References (29)

1. D. Leuci, G. Pomarico, N. Casucci, B. Fucci, N. D'Alitto, and A. Caldarone Primary prophylaxis of esophageal variceal bleeding in cirrhotic patients Recenti Prog. Med. 99 2008 607 610
2. S. Klein HSC-specific inhibition of Rho-kinase reduces portal pressure in cirrhotic rats without major systemic effects J. Hepatol. 57 2012 1220 1227
3. T. Bai, L.H. Lian, Y.L. Wu, Y. Wan, and J.X. Nan Thymoquinone attenuates liver fibrosis via PI3K and TLR4 signaling pathways in activated hepatic stellate cells Int. Immunopharmacol. 15 2013 275 281
4. J. Jiang, X. Ge, Z. Li, Y. Wang, Q. Song, D.W. Stanley, A. Tan, and Y. Huang MicroRNA-281 regulates the expression of ecdysone receptor (EcR) isoform B in the silkworm, Bombyx mori Insect Biochem. Mol. Biol. 43 2013 692 700
5. C.J. Guo, Q. Pan, D.G. Li, H. Sun, and B.W. Liu MiR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: an essential role for apoptosis J. Hepatol. 50 2009 766 778
6. C.J. Guo, Q. Pan, T. Cheng, B. Jiang, G.Y. Chen, and D.G. Li Changes in microRNAs associated with hepatic stellate cell activation status identify signaling pathways FEBS J. 276 2009 5163 5176
7. C.J. Guo, Q. Pan, B. Jiang, G.Y. Chen, and D.G. Li Effects of upregulated expression of microRNA-16 on biological properties of culture-activated hepatic stellate cells Apoptosis 14 2009 1331 1340
8. S.L. Friedman, and F.J. Roll Isolation and culture of hepatic lipocytes, Kupffer cells, and sinusoidal endothelial cells by density gradient centrifugation with Stractan Anal. Biochem. 161 1987 207 218
9. K. Ishak Histological grading and staging of chronic hepatitis J. Hepatol. 22 1995 696 699
10. N.K. Saxena, M.A. Titus, X. Ding, J. Floyd, S. Srinivasan, S.V. Sitaraman, and F.A. Anania Leptin as a novel profibrogenic cytokine in hepatic stellate cells: mitogenesis and inhibition of apoptosis mediated by extracellular regulated kinase (Erk) and Akt phosphorylation FASEB J. 18 2004 1612 1614
11. S. Dooley, J. Hamzavi, L. Ciuclan, P. Godoy, I. Ilkavets, S. Ehnert, E. Ueberham, R. Gebhardt, S. Kanzler, and A. Geier Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage Gastroenterology 135 2008 642 659
12. M. Yan, P. Zhu, H.M. Liu, H.T. Zhang, and L. Liu Ethanol induced mitochondria injury and permeability transition pore opening: role of mitochondria in alcoholic liver disease World J. Gastroenterol. 13 2007 2352 2356
13. D.C. Rockey, and R.A. Weisiger Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance Hepatology 24 1996 233 240
14. J. Meister, and M.H. Schmidt MiR-126 and miR-126*: new players in cancer ScientificWorldJournal 10 2010 2090 2100
15. J. Zhang, Y.Y. Du, Y.F. Lin, Y.T. Chen, L. Yang, H.J. Wang, and D. Ma The cell growth suppressor, miR-126, targets IRS-1 Biochem. Biophys. Res. Commun. 377 2008 136 140
16. Huang, F.; Fang, Z.F.; Hu, X.Q.; Tang, L.; Zhou, S.H. and Huang, J.P. Overexpression of miR-126 promotes the differentiation of mesenchymal stem cells toward endothelial cells via activation of PI3K/Akt and MAPK/ERK pathways and release of paracrine factors. Biol Chem. 394, 1223-1233.
17. N. Felli MiR-126&126* restored expressions play a tumor suppressor role by directly regulating ADAM9 and MMP7 in melanoma PLoS ONE 8 2013 e56824
18. R. Feng MiR-126 functions as a tumour suppressor in human gastric cancer Cancer Lett. 298 2010 50 63
19. I. Nikolic, K.H. Plate, and M.H. Schmidt EGFL7 meets miRNA-126: an angiogenesis alliance J. Angiogenes Res. 2 2010 9
20. Y. Liu PTK787/ZK22258 attenuates stellate cell activation and hepatic fibrosis in vivo by inhibiting VEGF signaling Lab. Invest. 89 2009 209 221
21. C.T. Tu, J.S. Guo, M. Wang, and J.Y. Wang Antifibrotic activity of rofecoxib in vivo is associated with reduced portal hypertension in rats with carbon tetrachloride-induced liver injury J. Gastroenterol. Hepatol. 22 2007 877 884
22. D. Thabut, and V. Shah Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension? J. Hepatol. 53 2010 976 980
23. J. Liang, X. Deng, Z.X. Lin, L.C. Zhao, and X.L. Zhang Attenuation of portal hypertension by natural taurine in rats with liver cirrhosis World J. Gastroenterol. 15 2009 4529 4537
24. M. Fernandez, M. Mejias, E. Garcia-Pras, R. Mendez, J.C. Garcia-Pagan, and J. Bosch Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats Hepatology 46 2007 1208 1217
25. B. Liu, X.C. Peng, X.L. Zheng, J. Wang, and Y.W. Qin MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo Lung Cancer 66 2009 169 175
26. M. Takahashi, A. Matsui, M. Inao, S. Mochida, and K. Fujiwara ERK/MAPK-dependent PI3K/Akt phosphorylation through VEGFR-1 after VEGF stimulation in activated hepatic stellate cells Hepatol. Res. 26 2003 232 236
27. 2+ channels in hepatic stellate cells Alcohol. Clin. Exp. Res. 24 2000 357 360
28. B. Wang, W. Li, K. Guo, Y. Xiao, Y. Wang, and J. Fan MiR-181b promotes hepatic stellate cells proliferation by targeting p27 and is elevated in the serum of cirrhosis patients Biochem. Biophys. Res. Commun. 421 2012 4 8
29. S.K. Venugopal, J. Jiang, T.H. Kim, Y. Li, S.S. Wang, N.J. Torok, J. Wu, and M.A. Zern Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation Am. J. Physiol. Gastrointest. Liver Physiol. 298 2010 G101 6